Sucralfate Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1 g
Reference Brands: Carafate(US)
Category:
Gastrointestinal Drugs
Sucralfate tablets form a protective barrier over stomach and duodenal ulcers, shielding them from stomach acid and enzymes. It promotes healing, relieves pain, and prevents ulcer complications. Benefits include faster ulcer healing, symptom relief, and gastrointestinal protection, supporting effective management of gastric and duodenal ulcers.
Sucralfate tablet is available in Tablets
and strengths such as 1 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sucralfate tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sucralfate tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sucralfate tablets, marketed as Carafate, are approved in the US by the FDA and in the EU via EMA for the treatment of gastric and duodenal ulcers. Regulatory approval requires a detailed dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for approved use, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability of sucralfate tablets, aiding ulcer healing and gastrointestinal protection worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing